Skip to main content
Premium Trial:

Request an Annual Quote

Proxeon Taps Europe, Asia Distributors

NEW YORK (GenomeWeb News) - Proteomics tools company Proxeon said today that it has expanded its reach in Europe and Asia through six new distribution agreements.

The European agreements include sales and marketing for Proxeon's tools in France, Greece, and Italy, and in the Asia-Pacific region pacts cover distribution in Singapore, South Korea, and Taiwan.

The Danish company's new European distributors include Proteomic Solutions in France, Rigas Labs in Greece, and Biosense in Italy. In the Asia-Pacific region, the new distributors include Scientech in Taiwan, Scinco in South Korea, and Alpha Analytical in Singapore.

The company sells the Easy-nLC system and ProteinCenter protein identification and data interpretation platform for mass spectrometry research efforts.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.